Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Chelation of bismuth by combining desferrioxamine and deferiprone in rats

View through CrossRef
Consumption and production of bismuth compounds are increasing, however, a little information on the toxic effect and also the effective method in removal of bismuth compounds are available. The present research aimed to characterize the potential efficiency of two chelators after bismuth administration for 55 days following two dose levels of 20 and 40 mg/kg body weight daily to male rats. However, we found abnormalities after bismuth administration in clinical signs, such as body weight, kidneys and liver damages, a black line on gums and skin reactions. Furthermore, the hypothesis that the two chelators might be more efficient as combined therapy than as single therapy in removing bismuth from the body was considered. Along this line, two known chelators deferiprone (1, 2-dimethy1-3-hydroxypyride-4-one, L 1 ) and desferrioxamine (DFO) were chosen and tested in the acute rat model. Chelators were given orally (L 1 ) or intraperitoneally (DFO) as a single or combined therapy for the period of a week. Doses of L 1 and DFO were 110 mg/kg body weight in experiments. Bismuth and iron concentrations in various tissues were determined by graphite furnace and flame atomic absorption spectrometry, respectively. The combined chelation therapy results show that DFO and L 1 are able to remove bismuth ions from the body, whereas iron concentration returned to the normal level and symptoms are also decreased. DFO was more effective than L1 in reducing bismuth concentration in tissues. The efficiency of DFO + L 1 is more than DFO or L 1 in removing bismuth from organs. Our results are indicative that the design procedure might be useful for preliminary in-vivo testing of the efficiency of chelating agents. Results of combined chelators’ treatment should be confirmed in a different experimental model before extrapolation to other systems. This testing procedure of course does not provide all the relevant answers for efficiency of chelating agents in bismuth toxicity.
Title: Chelation of bismuth by combining desferrioxamine and deferiprone in rats
Description:
Consumption and production of bismuth compounds are increasing, however, a little information on the toxic effect and also the effective method in removal of bismuth compounds are available.
The present research aimed to characterize the potential efficiency of two chelators after bismuth administration for 55 days following two dose levels of 20 and 40 mg/kg body weight daily to male rats.
However, we found abnormalities after bismuth administration in clinical signs, such as body weight, kidneys and liver damages, a black line on gums and skin reactions.
Furthermore, the hypothesis that the two chelators might be more efficient as combined therapy than as single therapy in removing bismuth from the body was considered.
Along this line, two known chelators deferiprone (1, 2-dimethy1-3-hydroxypyride-4-one, L 1 ) and desferrioxamine (DFO) were chosen and tested in the acute rat model.
Chelators were given orally (L 1 ) or intraperitoneally (DFO) as a single or combined therapy for the period of a week.
Doses of L 1 and DFO were 110 mg/kg body weight in experiments.
Bismuth and iron concentrations in various tissues were determined by graphite furnace and flame atomic absorption spectrometry, respectively.
The combined chelation therapy results show that DFO and L 1 are able to remove bismuth ions from the body, whereas iron concentration returned to the normal level and symptoms are also decreased.
DFO was more effective than L1 in reducing bismuth concentration in tissues.
The efficiency of DFO + L 1 is more than DFO or L 1 in removing bismuth from organs.
Our results are indicative that the design procedure might be useful for preliminary in-vivo testing of the efficiency of chelating agents.
Results of combined chelators’ treatment should be confirmed in a different experimental model before extrapolation to other systems.
This testing procedure of course does not provide all the relevant answers for efficiency of chelating agents in bismuth toxicity.

Related Results

Iron Chelation Efficiency in Human Hepatocytes Is Enhanced By Exogenous Hepcidin
Iron Chelation Efficiency in Human Hepatocytes Is Enhanced By Exogenous Hepcidin
Iron chelation is clinically inefficient, with only a small percentage of the applied chelator being excreted in the iron-bound form. Chelation is also slow because only a small pr...
Bismuth and Bismuth Alloys
Bismuth and Bismuth Alloys
Abstract The element bismuth, Bi, found in Group 15 (VA) of the Periodic Table, has at no. 83, at wt 208.98. Its valences are +5 and +3. Bismuth is a silvery metal having...
Bismuth and Bismuth Alloys
Bismuth and Bismuth Alloys
Abstract The element bismuth, Bi, found in Group 15 (VA) of the Periodic Table, has at no. 83, at wt 208.98. Its valences are \doc...
Deferiprone increases endothelial nitric oxide synthase phosphorylation and nitric oxide production
Deferiprone increases endothelial nitric oxide synthase phosphorylation and nitric oxide production
Iron chelation can improve endothelial function. However, effect on endothelial function of deferiprone has not been reported. We hypothesized deferiprone could promote nitric oxid...
Prevention of heart disease by subcutaneous desferoxamine in patients with thalassaemia major
Prevention of heart disease by subcutaneous desferoxamine in patients with thalassaemia major
Abstract Background: Cardiac siderosis from transfused iron remains the major cause of death in thalassaemia major, despite iron chelation therapy with desferrioxamine. Aims: Our a...
Electrochemical Synthesis of Bismuth Iodide and Bismuth Oxyiodide
Electrochemical Synthesis of Bismuth Iodide and Bismuth Oxyiodide
This study reports the electrochemical synthesis of bismuth iodide and bismuth oxyiodide from acidic baths containing bismuth nitrate, sodium nitrate, iodine and ethylene glycol by...
Synthesis and application of bismuth alkoxide and bismuth titanate
Synthesis and application of bismuth alkoxide and bismuth titanate
Recently, bismuth containing material was used in a number of applications such as sensor, photocatalyst, and electronics. For instance, bismuth titanate sillenite phase performed ...

Back to Top